Infosys Foundation and the Centre for Cellular and Molecular Platforms to Strengthen Maternity Care in Karnataka

Infosys Foundation, the philanthropic and CSR arm of Infosys, today announced its collaboration with the Centre for Cellular and Molecular Platforms (C-CAMP), a Department of Biotechnology, Government of India supported initiative. This collaboration marks the launch of the ‘C-CAMP-Infosys Foundation Project Early Life’, which is aimed at bolstering maternity care, both for expectant mothers and newborns, in Karnataka, using innovative medical technologies.

The C-CAMP-Infosys Foundation Project Early Life was launched at the Government of Karnataka's roundtable on health titled ‘A new paradigm with CSR and Philanthropy’, in association with C-CAMP, that was chaired by Shri Dinesh Gundu Rao, Hon’ble Minister for Health and Family Welfare, Government of Karnataka. Infosys Foundation has committed INR 8.5 crore towards this project, which will address the early adoption of healthcare technology at low-resource health facilities to improve maternal health screening as well as address the rising cases of neonatal mortality.

As part of this project, a cutting-edge fetal monitoring technology will be deployed to enhance health monitoring of expectant mothers across district hospitals and community health centres, in Karnataka. In addition, a neonatal Continuous Positive Airway Pressure device, which provides respiratory support for newborns in respiratory distress, will be made available across critical care newborn units in district and taluk hospitals. This collaboration aims to benefit about 50,000 to 1 lakh women and 4,000 newborns, across eight districts in the state, over a period four years.

Shri Dinesh Gundu Rao, Hon’ble Minister, Health and Family Welfare, Government of Karnataka, said, “Improving Maternal and newborn healthcare in the districts is a very important priority for us. We will be starting with Dharwad and Ballari and cover a total of eight districts to strengthen health monitoring for all mothers and quality care to newborns requiring critical care support. I whole-heartedly appreciate C-CAMP and Infosys Foundation for taking this initiative, this program will definitely make quality healthcare accessible to the masses in Karnataka’s districts.”

Dr. Taslimarif Saiyed, CEO and Director, C-CAMP, said, “We appreciate the support of Infosys Foundation and its contribution towards enhancing and improving the healthcare infrastructure for the underserved. This initiative furthers our collective endeavour of leveraging advanced technology built indigenously to provide quality care to mothers and their newborns, and creating avenues for affordable and accessible healthcare in Karnataka.”

Sunil Kumar Dhareshwar, Trustee, Infosys Foundation, said, “Maternity care has been a key area of focus for Infosys Foundation within the healthcare space. The ‘C-CAMP-Infosys Foundation Project Early Life’ will not only give a boost to the public healthcare infrastructure in the state, but also give impetus to the adoption of innovative technologies in maternal and childcare. We are grateful for the support of the Centre for Cellular and Molecular Platforms as we strive to make quality healthcare accessible to the masses.”

About Centre for Cellular and Molecular Platforms (C-CAMP)

The Centre for Cellular and Molecular Platforms (C-CAMP) is an initiative supported by the Department of Biotechnology (DBT), Govt. of India. It is India's premier hub for life sciences innovation and entrepreneurship and is working very closely with Central and various State Governments. C-CAMP has supported innovation of 400+ technologies through funding, incubation, mentorship, and other advancement programs. C-CAMP has recently entered into a partnership MoU with the Dept. of Health and Family Welfare Services, Government of Karnataka. C-CAMP's Technology Impact Programme (C-TIP) strengthens the public health system by deploying innovative technologies that address Govt. of India's policy initiatives and United Nations' Sustainable Development Goals through the support of funding partners. This has led to partnerships with key national and state health system stakeholders, in order to provide health technology solutions for augmenting public health infrastructure, in PHCs, CHCs, district hospitals, and so on. Additionally, its efforts generate evidence to showcase the role of public-private partnerships in creating pathways for scaling relevant technology solutions for societal impact.

About Infosys Foundation

Established in 1996, the Infosys Foundation supports programs in the areas of education, rural development, healthcare, women empowerment, arts and culture, and destitute care. Its mission is to work with the underprivileged across the country and strive towards a more equitable society. The Infosys Foundation takes pride in working with all sections of society, selecting projects with infinite care, and working in areas that are traditionally overlooked by society at large.

For more details, please log on: https://www.infosys.com/infosys-foundation

About Infosys

Infosys is a global leader in next-generation digital services and consulting. Over 300,000 of our people work to amplify human potential and create the next opportunity for people, businesses and communities. We enable clients in more than 56 countries to navigate their digital transformation. With over four decades of experience in managing the systems and workings of global enterprises, we expertly steer clients, as they navigate their digital transformation powered by cloud and AI. We enable them with an AI-first core, empower the business with agile digital at scale and drive continuous improvement with always-on learning through the transfer of digital skills, expertise, and ideas from our innovation ecosystem. We are deeply committed to being a well-governed, environmentally sustainable organization where diverse talent thrives in an inclusive workplace.

Visit www.infosys.com to see how Infosys (NSE, BSE, NYSE: INFY) can help your enterprise navigate your next.

Safe Harbor

Certain statements in this release concerning our future growth prospects, or our future financial or operating performance, are forward-looking statements intended to qualify for the 'safe harbor' under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the execution of our business strategy, our ability to attract and retain personnel, our transition to hybrid work model, economic uncertainties, technological innovations such as Generative AI, the complex and evolving regulatory landscape including immigration regulation changes, our ESG vision, our capital allocation policy and expectations concerning our market position, future operations, margins, profitability, liquidity, capital resources, our corporate actions including acquisitions, and cybersecurity matters. Important factors that may cause actual results or outcomes to differ from those implied by the forward-looking statements are discussed in more detail in our US Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2023. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company's filings with the Securities and Exchange Commission and our reports to shareholders. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law.

Media contacts:

For further information, please contact: PR_Global@Infosys.com